Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.350
+0.190 (16.38%)
At close: Jul 21, 2025, 4:00 PM
1.540
+0.190 (14.07%)
Pre-market: Jul 22, 2025, 9:25 AM EDT

Health In Tech Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Health In Tech stock has a target of 2.5, which predicts a 85.19% increase from the current stock price of 1.35.

Price Target: $2.5 (+85.19%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$2.50$2.50$2.50$2.50
Change+85.19%+85.19%+85.19%+85.19%

Analyst Ratings

According to 1 stock analyst, the rating for Health In Tech is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJul '25
Strong Buy1
Buy0
Hold0
Sell0
Strong Sell0
Total1

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Strong Buy
Initiates
$2.5
Strong BuyInitiates$2.5+85.19%Jun 26, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
29.25M
from 19.49M
Increased by 50.09%
Revenue Next Year
41.31M
from 29.25M
Increased by 41.21%
EPS This Year
0.03
from 0.01
Increased by 152.50%
EPS Next Year
0.12
from 0.03
Increased by 380.00%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
5.77M19.15M19.49M29.25M41.31M62.01M
Revenue Growth
-231.93%1.77%50.09%41.21%50.12%
EPS
0.000.050.010.030.120.25
EPS Growth
-2,788.89%-79.10%152.50%380.00%108.33%
Forward PE
---53.4711.145.35
No. Analysts
---322
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High32.2M42.9M64.5M
Avg29.3M41.3M62.0M
Low26.7M40.1M60.2M

Revenue Growth

Revenue Growth202520262027
High
65.1%
46.8%
56.1%
Avg
50.1%
41.2%
50.1%
Low
37.2%
37.0%
45.7%

EPS Forecast

EPS202520262027
High0.030.130.26
Avg0.030.120.25
Low0.020.120.25

EPS Growth

EPS Growth202520262027
High
215.0%
399.0%
116.6%
Avg
152.5%
380.0%
108.3%
Low
96.0%
365.7%
102.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.